Stay updated on Safety Tolerability in IPF Clinical Trial

Sign up to get notified when there's something new on the Safety Tolerability in IPF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Tolerability in IPF Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T15:29:27.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T01:50:02.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed study descriptions and eligibility criteria for a clinical trial on Idiopathic Pulmonary Fibrosis (IPF), while retaining the study's name and location. The revision number has also been updated.
    Difference
    36%
    Check dated 2025-04-16T14:19:57.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:11:29.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T21:07:54.000Z thumbnail image
  8. Check
    110 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T10:16:29.000Z thumbnail image

Stay in the know with updates to Safety Tolerability in IPF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Tolerability in IPF Clinical Trial page.